RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 90 filers reported holding RELMADA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,000 | +22.0% | 3,000 | 0.0% | 0.00% | – |
| Q2 2023 | $7,380 | +8.8% | 3,000 | 0.0% | 0.00% | – |
| Q1 2023 | $6,780 | -35.2% | 3,000 | 0.0% | 0.00% | – |
| Q4 2022 | $10,470 | -90.6% | 3,000 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $111,000 | +94.7% | 3,000 | 0.0% | 0.00% | – |
| Q2 2022 | $57,000 | -29.6% | 3,000 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $81,000 | -40.0% | 3,000 | -50.0% | 0.00% | 0.0% |
| Q4 2021 | $135,000 | -14.0% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $157,000 | -18.2% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $192,000 | -9.0% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $211,000 | +9.9% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $192,000 | -15.0% | 6,000 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $226,000 | -16.0% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $269,000 | +31.2% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $205,000 | -12.4% | 6,000 | 0.0% | 0.00% | +100.0% |
| Q4 2019 | $234,000 | – | 6,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 668,440 | $25,147,000 | 4.92% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $18,810,000 | 3.40% |
| ACUTA CAPITAL PARTNERS, LLC | 277,000 | $10,421,000 | 2.83% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 455,137 | $17,122,000 | 1.67% |
| RTW INVESTMENTS, LP | 1,511,337 | $56,857,000 | 1.37% |
| Avoro Capital Advisors LLC | 1,500,000 | $56,430,000 | 0.80% |
| Pegasus Asset Management, Inc. | 26,958 | $1,014,000 | 0.64% |
| RA Capital Management | 781,290 | $29,392,000 | 0.54% |
| TIEDEMANN ADVISORS, LLC | 269,839 | $10,151,000 | 0.49% |
| Boxer Capital, LLC | 300,000 | $11,286,000 | 0.39% |